Dual-action antibodies deliver stronger attack on tumors

Researchers have engineered antibodies that combine two cancer-fighting mechanisms, enhancing their ability to target and destroy tumors. The dual-action approach shows promise for more effective cancer immunotherapy treatments in preclinical studies.

Sources (1)